Does physical activity help relieve depression in children and adolescents? We know it helps adults, but what is the evidence in kids? This research update looks at a study that tries to elucidate the effectiveness of exercise on depression in kids and teens, and how much to emphasize exercise with your own patients.

How do lithium and quetiapine compare in their ability to treat acute mania in children and teens? Are they effective? Do kids go into remission? And how do their side effect profiles compare?  This clinical update can help you decide which patients might be good candidates for which medication. 

Vortioxetine has to be reasonably tolerated in children and teens, with manageable side effects, to have any chance of inclusion into treatment for anxiety or depression. This research update gives you the latest on whether vortioxetine might be a viable approach even before we have good efficacy studies. 

We struggle to manage the metabolic impact of antipsychotic medications on the children and teens we treat. Could topiramate be a viable option for our armamentarium of strategies? Read our research update to find out. 

Lithium is FDA-approved for bipolar disorder in children and adolescents 12 years and up; however, its potential off-label utility is broad, from affective aggression to anorexia nervosa. This clinical update covers how to prescribe lithium for children and adolescents and how to talk with patients and parents about lithium. 

Deep Brain Stimulation is a surgically invasive procedure that is used in an attempt to treat several conditions including obsessive compulsive disorder in some youths. But does it work? Read our research update so you can better guide families on this high-risk decision.